Published in Biol Blood Marrow Transplant on August 24, 2011
Alternative donor hematopoietic cell transplantation for Fanconi anemia. Blood (2015) 1.49
Second Allogeneic Hematopoietic Cell Transplantation for Patients with Fanconi Anemia and Bone Marrow Failure. Biol Blood Marrow Transplant (2015) 0.77
Cyclophosphamide promotes engraftment of gene-modified cells in a mouse model of Fanconi anemia without causing cytogenetic abnormalities. J Mol Med (Berl) (2012) 0.75
Fanconi anemia associated with moyamoya disease in Saudi Arabia. Saudi Med J (2015) 0.75
Allogeneic-matched sibling stem cell transplantation in a 13-year-old boy with ataxia telangiectasia and EBV-positive non-Hodgkin lymphoma. Bone Marrow Transplant (2016) 0.75
Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5). Blood (2012) 1.82
Role of phosphatidylinositol 3'-kinase/AKT pathway in diffuse large B-cell lymphoma survival. Blood (2006) 1.70
Clinical characteristics and treatment outcome of pediatric patients with chronic myeloid leukemia. Haematologica (2010) 1.53
Human herpesvirus 7 in pediatric hematopoietic stem cell transplantation. Pediatr Blood Cancer (2007) 1.46
Clinical characteristics and outcome of children with biphenotypic acute leukemia. Haematologica (2009) 1.07
Overexpression of FoxM1 offers a promising therapeutic target in diffuse large B-cell lymphoma. Haematologica (2012) 0.91
Dexamethasone-associated toxicity during induction chemotherapy for childhood acute lymphoblastic leukemia is augmented by concurrent use of daunomycin. Cancer (2003) 0.91
Prevalence of fragile histidine triad expression in tumors from saudi arabia: a tissue microarray analysis. Cancer Epidemiol Biomarkers Prev (2006) 0.88
Outcome and toxicity of chemotherapy for acute lymphoblastic leukemia in children with Down syndrome. Pediatr Blood Cancer (2009) 0.87
Genetic polymorphisms of methylenetetrahydrofolate reductase and promoter methylation of MGMT and FHIT genes in diffuse large B cell lymphoma risk in Middle East. Ann Hematol (2007) 0.83
Second stem cell transplantation in patients with Fanconi anemia using antithymocyte globulin alone for conditioning. Biol Blood Marrow Transplant (2008) 0.82
Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency. Biol Blood Marrow Transplant (2010) 0.81
Cytomegalovirus retinitis in children and young adults with acute lymphoblastic leukemia in Lebanon. Leuk Lymphoma (2014) 0.80
Vincristine-itraconazole interaction: cause for increasing concern. J Pediatr Hematol Oncol (2002) 0.80
A novel HAX1 gene mutation in severe congenital neutropenia (SCN) associated with neurological manifestations. Eur J Pediatr (2010) 0.79
Efficacy of vincristine and carboplatin as chemo-reduction for advanced bilateral retinoblastoma, the Saudi experience. Saudi J Ophthalmol (2013) 0.79
Outcome and prognostic factors of acute lymphoblastic leukemia in children at the National Cancer Institute, Egypt. J Pediatr Hematol Oncol (2004) 0.78
Outcome of pediatric patients with lymphoma following stem cell transplant: a single institution report. Leuk Lymphoma (2014) 0.78
Outcome of second allogenic stem cell transplantation in pediatric patients with non-malignant hematological and immune deficiency disorders. Pediatr Blood Cancer (2010) 0.77
Allogeneic hematopoietic stem cell transplantation in leukocyte adhesion deficiency type 1: a single center experience. Biol Blood Marrow Transplant (2011) 0.77
Outcome of Ewing sarcoma in a multidisciplinary setting in Lebanon. Pediatr Blood Cancer (2014) 0.77
Epstein-Barr virus infection is not the sole cause of high prevalence for Hodgkin's lymphoma in Saudi Arabia. Leuk Lymphoma (2006) 0.76
The prevalence of factor VIII and IX inhibitors among Saudi patients with hemophilia: Results from the Saudi national hemophilia screening program. Medicine (Baltimore) (2017) 0.75
Does adding ATG to the GVHD prophylaxis regimen help reduce its incidence? Bone Marrow Transplant (2003) 0.75
Idiopathic colonic calcification: a case report. Ger Med Sci (2013) 0.75
Cyclophosphamide and topotecan as first-line salvage therapy in patients with relapsed ewing sarcoma at a single institution. J Pediatr Hematol Oncol (2013) 0.75
In cyclosporine induced neurotoxicity, is tacrolimus an appropriate substitute or is it out of the frying pan and into the fire? Pediatr Blood Cancer (2008) 0.75
Improved outcome for children with acute lymphoblastic leukemia after risk-adjusted intensive therapy: a single-institution experience. Ann Saudi Med (2008) 0.75
High throughput tissue microarray analysis of FHIT expression in diffuse large cell B-cell lymphoma from Saudi Arabia. Mod Pathol (2006) 0.75
Outcome of allogeneic stem cell transplantation with a conditioning regimen of busulfan, cyclophosphamide and low-dose etoposide for children with myelodysplastic syndrome. Hematol Oncol Stem Cell Ther (2011) 0.75
Development and implementation of a distributed integrated data-management system for pediatric hematology/oncology service: a modular approach for a clinical outcome and research information system. J Registry Manag (2012) 0.75
The outcome of children with acute myeloid leukemia (AML) post-allogeneic stem cell transplantation (SCT) is not improved by the addition of etoposide to the conditioning regimen. Pediatr Blood Cancer (2006) 0.75
Factors Determining the Outcome of Hematopoietic Stem Cell Transplantation in Patients With Acute Lymphoblastic Leukemia at King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. J Pediatr Hematol Oncol (2016) 0.75
Intra-leukocytic hemosiderin inclusions detected as pseudoeosinophils by automated depolarization analysis in a patient with beta-thalassaemia major and immune hemolysis. Blood Cells Mol Dis (2005) 0.75
Outcome of risk adapted therapy for relapsed/refractory acute lymphoblastic leukemia in children. Leuk Lymphoma (2012) 0.75